Chorionic gonadotrophin (Merck & Co)

绒毛膜促性腺激素（默沙东）

Report date: 2026/03/07 20:00:27

Base Information

Drug NameChorionic gonadotrophin (Merck & Co)
Drug Alias NameUrinary-derived human chorionic gonadotropin and epidermal growth factorPregnylProfasi
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptorLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsGraft vs Host DiseaseHypogonadismInfertility, Female +[5] 
Global Approved IndicationsHypogonadismInfertility, FemaleCryptorchidism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1976/10/20
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, GermanyMasonic Cancer Center, University Of MinnesotaOrganon Usa Inc +[4] 
Inactive CompaniesN/A
Active IndicationsGraft vs Host DiseaseHypogonadismInfertility, Female +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeG03GA01
Related LinksN/A